The R3i Foundation (Residual Risk Reduction Initiative), an independent, multinational and academic organization, is conducting the REALIST (Residual Risk, Lipids and Standard Therapies) study in 40 centers in different countries.
Broad partnerships are vital to conquering the HIV/AIDS pandemic, and UNICEF is key to strengthening partnerships with UNAIDS, multinational agencies, academic and research institutions, non-governmental organizations and the private sector.
Writers have had patrons in the past, but I fear the day when multinational corporations sponsor academics and publishers and authors to frame things from their point of view, and manage not to slap their logos all over it like a warning.
On the other hand, if your prior bias is toward the idea that there is a massive plot by huge multinational environmental corporations, academics and hippies to deprive you of the right to drive the kids to school in a humvee, you will place a much lower weight on mounting evidence of anthropogenic climate change.
This component is build up around a Consortium of Italian universities (none of them appearing as assignee), international universities, multinational private firms and foreign academic inventors.
Perceptible efforts have been made to address the challenges faced by academics in less-developed regions by European and American multinational publishing firms that dominate global academic publishing.
The practice of collecting data from Asia is likely to have emerged in the early 1990s when Chinese people became more mobile, leading to the growth in the number of China-based multinational enterprises (MNEs) and Chinese academics who had studied and worked abroad.
We estimate that this multinational collaboration of many of the academic foci for AIP permitted analysis of a significant proportion of the world's current AIP population.
But "multinational companies like Japanese experience," asserted one senior academic.
Pharmaceutical companies, ranging in size from multinational giants to small biotechnology outfits, and large academic institutions have established drug discovery programmes that have already introduced a large number of novel compounds into early phase clinical trials in a wide range of tumour types.
